BARI USA

(redirected from Bypass Angioplasty Revascularization Investigation)
Also found in: Acronyms.

BARI USA

Bypass Angioplasty Revascularization Investigation USA. A trial comparing the pros and cons of percutaneous transluminal angioplasty (PTCA) to coronary artery bypass graft surgery (CABG) in managing patients with multivessel coronary artery disease.
 
Conclusion 
(1) No difference in survival;
(2) PTCA carries an increased need for late repeat revascularisation;
(3) PCTA has an increased mortality in diabetics.
References in periodicals archive ?
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) Circulation 1997;96:1761-9.
Reference The Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
But this represents a considerable narrowing of the historic gap between the two strategies observed in earlier classic studies such as the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty vs.
In the 1996 Bypass Angioplasty Revascularization Investigation, diabetic patients fared better with CABG than with PTCA.